Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

by Benjamin D. Horne, Petra A. Lenzini, Mia Wadelius, Andrea L. Jorgensen, Stephen E. Kimmel, Paul M. Ridker, Niclas Eriksson, Jeffrey L. Anderson, Munir Pirmohamed, Nita A. Limdi, Robert C. Pendleton, Gwendolyn A. Mcmillin, James K. Burmester, Daniel Kurnik, C. Michael Stein, Michael D. Caldwell, Charles S. Eby, Anders Rane, Jonatan D. Lindh, Jae Gook Shin, Ho Sook Kim, Pantep Angchaisuksiri, Robert J. Glynn, Kathryn E. Kronquist, John F. Carlquist, Gloria R. Grice, Robert L. Barrack, Juan Li, Brian F. Gage
Published 2018